Haemophilus Asparaginase chrysanthemi, Jazz Pharma, Rylaze
Nova dosing regimen pro asparaginasi erwinia chrysanthemi (recombinante) approbatur a FDA.
Dec 2022: Nova Lunae-Wednesday-Friday cedula dosing pro asparaginasis erwinia chrysanthemi (recombinante) -rywn a Cibus et medicamentis administrationis approbata est (Rylaze, Jazz Pharmaceuticals). Aegroti 25 mg/m recipiant.
Haemophilus Asparaginase chrysanthemi, Jazz Pharma, JZP458-201, NCT04145531, Rylaze
FDA probatus asparaginase Erwinia chrysanthemi (recombinant) ad leukemia et lymphoma
August MMXXI: The Cibus et medicamentis Administration approbavit asparaginase Erwinia chrysanthemi (recombinant) -rywn) (Rylaze, Jazz Pharmaceuticals, Inc.) as of a multi-pars victus agente chemotherapeutic ad curatio acuti lym ..